These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8921954)

  • 1. Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma.
    Bogen B
    Eur J Immunol; 1996 Nov; 26(11):2671-9. PubMed ID: 8921954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies.
    Bogen B; Munthe L; Sollien A; Hofgaard P; Omholt H; Dagnaes F; Dembic Z; Lauritzsen GF
    Eur J Immunol; 1995 Nov; 25(11):3079-86. PubMed ID: 7489746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal deletion of thymocytes as a tumor escape mechanism.
    Lauritzsen GF; Hofgaard PO; Schenck K; Bogen B
    Int J Cancer; 1998 Oct; 78(2):216-22. PubMed ID: 9754655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
    Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells.
    Lauritzsen GF; Bogen B
    Cell Immunol; 1993 Apr; 148(1):177-88. PubMed ID: 8098665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic selection of immunoglobulin idiotype specific T-cells.
    Dembić Z; Weiss S; Bogen B
    Thymus; 1994; 22(3):141-52. PubMed ID: 7940642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.
    Fink PJ; Fang CA; Turk GL
    J Immunol; 1994 May; 152(9):4270-81. PubMed ID: 7908916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gut-homing, oligoclonal CD4+ T cell population in severe-combined immunodeficient mice expressing a rearranged, transgenic class I-restricted alpha beta T cell receptor.
    Reimann J; Rudolphi A; Spiess S; Claesson MH
    Eur J Immunol; 1995 Jun; 25(6):1643-53. PubMed ID: 7614993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulation by processed immunoglobulin on B-cells.
    Ghosh SK; Chakrabarti D
    Indian J Biochem Biophys; 1993 Dec; 30(6):414-21. PubMed ID: 7911781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities.
    Bogen B; Gleditsch L; Weiss S; Dembic Z
    Eur J Immunol; 1992 Mar; 22(3):703-9. PubMed ID: 1547816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.
    van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS
    J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
    Lieberman SA; Spain LM; Wang L; Berg LJ
    Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic modulation of the TCR repertoire in the lymphoid periphery.
    Blish CA; Gallay BJ; Turk GL; Kline KM; Wheat W; Fink PJ
    J Immunol; 1999 Mar; 162(6):3131-40. PubMed ID: 10092762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
    Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo mechanisms of acquired thymic tolerance.
    Chen W; Issazadeh S; Sayegh MH; Khoury SJ
    Cell Immunol; 1997 Aug; 179(2):165-73. PubMed ID: 9268500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.